Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2024 | 2 |
Cited In for PMID: 36260549
3 results
Results by year
Filters applied: . Clear all
Page 1
Examining the relationship between metformin dose and cancer survival: A SEER-Medicare analysis.
PLoS One. 2022 Oct 19;17(10):e0275681. doi: 10.1371/journal.pone.0275681. eCollection 2022.
PLoS One. 2022.
PMID: 36260549
Free PMC article.
Anticarcinogenic Effects of Gold Nanoparticles and Metformin Against MCF-7 and A549 Cells.
Yeşildağ A, Kızıloğlu HT, Dirican E, Erbaş E, Gelen V, Kara A.
Yeşildağ A, et al.
Biol Trace Elem Res. 2024 Oct;202(10):4494-4507. doi: 10.1007/s12011-024-04090-y. Epub 2024 Feb 15.
Biol Trace Elem Res. 2024.
PMID: 38358644
Free PMC article.
Item in Clipboard
Metronomic cyclophosphamide and metformin inhibited tumor growth and repopulated tumor-infiltrating lymphocytes in an experimental carcinoma model.
Zaki HM, Ali KM, Abd Allah MYY, Abouelnaga AM, Abdraboh ME, Hussein O.
Zaki HM, et al.
BMC Res Notes. 2024 Jan 2;17(1):4. doi: 10.1186/s13104-023-06651-1.
BMC Res Notes. 2024.
PMID: 38167322
Free PMC article.
Item in Clipboard
Cite
Cite